Results 61 to 70 of about 3,492,596 (401)

An aptamer-biosensor for azole class antifungal drugs [PDF]

open access: yes, 2017
This report describes the development of an aptamer for sensing azole antifungal drugs for therapeutic drug monitoring. Modified Synthetic Evolution of Ligands through Exponential Enrichment (SELEX) was used to discover a DNA aptamer recognizing azole class antifungal drugs.
arxiv   +1 more source

Fungal biofilm resistance [PDF]

open access: yes, 2012
Fungal biofilm infections have become increasingly recognised as a significant clinical problem. One of the major reasons behind this is the impact that these have upon treatment, as antifungal therapy often fails and surgical intervention is required ...
Rajendran, Ranjith   +3 more
core   +4 more sources

A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases

open access: yesSaudi Pharmaceutical Journal, 2023
Human pathogenic fungi are responsible for causing a range of infection types including mucosal, skin, and invasive infections. Life-threatening and invasive fungal infections (FIs) are responsible for mortality and morbidity, especially for individuals ...
Osama A. Madkhali
doaj  

In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules [PDF]

open access: yes, 2014
Candida infections have created a great burden on the public healthcare sector. The situation is worsened by recent epidemiological changes. Furthermore, the current arsenal of antifungal agents is limited and associated with undesirable drawbacks ...
Samaranayake, Lakshman P.   +2 more
core   +1 more source

Fungal Drug Response and Antimicrobial Resistance

open access: yesJournal of Fungi, 2023
Antifungal resistance is a growing concern as it poses a significant threat to public health. Fungal infections are a significant cause of morbidity and mortality, especially in immunocompromised individuals.
Paloma Osset-Trénor   +2 more
doaj   +1 more source

Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.

open access: yesFuture Medicinal Chemistry, 2019
Fungal infections are a worldwide problem associated with high morbidity and mortality. There are relatively few antifungal agents, and resistance has emerged within these pathogens for the newest antifungal drugs. As the fungal cell wall is critical for
S. Hasim, Jeffrey J. Coleman
semanticscholar   +1 more source

Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance [PDF]

open access: yes, 2018
Candida auris has emerged as a significant global nosocomial pathogen. This is primarily due to its antifungal resistance profile but also its capacity to form adherent biofilm communities on a range of clinically important substrates.
Ben-Ami   +63 more
core   +3 more sources

Chalcone derivatives as potential antifungal agents: Synthesis, and antifungal activity

open access: yesJournal of Advanced Pharmaceutical Technology & Research, 2015
Much research has been carried out with the aim to discover the therapeutic values of chalcone derivatives. Chalcones possess wide range of pharmacological activity such as antibacterial, antimalarial, antiprotozoal, antitubercular, anticancer, and ...
Deepa Gupta, D K Jain
doaj   +1 more source

Synthesis of Antifungal Heterocycle-Containing Mannich Bases: A Comprehensive Review

open access: yesOrganics, 2023
Mannich bases are a class of organic compounds usually obtained by the condensation reaction between an amine, a compound with active hydrogens, and an aldehyde.
Diego Quiroga, Ericsson Coy-Barrera
doaj   +1 more source

Quantitative Analysis of Candida Cell Wall Components by Flow Cytometrywith Triple-Fluorescence Staining [PDF]

open access: yes, 2017
This work was supported by the European Commission within the FP7 Framework Programme [Fungitect-Grant No 602125]. We also thank Thomas Sauer, Vienna Biocenter Campus (VBC), Austria, for technical support at the FACS facility of the MFPL, Karl Kuchler ...
Gow, N   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy